Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Conatus Pharmaceuticals Inc.

www.conatuspharma.com

Latest From Conatus Pharmaceuticals Inc.

Boehringer Adds Yuhan’s First-In-Class Dual Agonist To NASH Portfolio

Yuhan reaches $870m NASH licensing-out deal with Boehringer, touting its competitiveness in the space after earlier alliance with Gilead. The collaboration for first-in-class GLP-1/FGF21 dual agonist is poised to beef up German firm's R&D expertise in cardiometabolic disease.

South Korea Deals

Conatus Accepts Defeat For Emricasan In NASH

After multiple Phase IIb trial failures, Conatus says it will fulfill contractual obligations and consider strategic alternatives. Partner Novartis was already focused on other candidates and partnerships in NASH.

Clinical Trials Business Strategies

Novartis’s NASH Chief: Our Strategy Is Combos With Tropifexor As ‘Backbone’

Novartis's broad but early-stage NASH pipeline will use FXR agonist tropifexor as its keystone for developing combination therapies with outside partners.

Research and Development Strategies Liver & Hepatic

Conatus Endures Another NASH Setback With Failure To Hit Fibrosis Endpoint

The pan-caspase inhibitor emricasan, partnered with Novartis, misses fibrosis-reduction endpoint in Phase IIb study, following the failure last December of a trial in portal hypertension.

Liver & Hepatic Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Hepatic (Liver)
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Conatus Pharmaceuticals Inc.
  • Senior Management
  • Steven J Mento, PhD, Pres. & CEO
    Michelle L Vandertie, VP, Fin.
    Daniel L Ripley, VP, Bus. Dev. & Program Alliance Mgt.
    Alfred P Spada, PhD, EVP, R&D & CSO
  • Contact Info
  • Conatus Pharmaceuticals Inc.
    Phone: (858) 376-2600
    16745 West Bernardo Dr.
    Ste. 200
    San Diego, CA 92127
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register